Picard Medical Inc. Reports 207% Increase in Revenue for <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Compared to Q2 2024
Picard Medical Inc. released its financial results for the quarter ending June 30, 2025. The company reported an increase in total revenues to $2.131 million, up from $0.694 million in the same period of 2024, marking a 207% increase. The revenue growth was entirely driven by product sales, as rental revenues remained unchanged. The cost of revenues also rose, reaching $2.258 million from $1.076 million in the previous year, an increase of 110%. This includes a 116% rise in the cost of products and a 97% rise in rental costs. Picard Medical Inc. indicated expectations to incur increased costs associated with establishing sales, marketing, and revenue growth. The company did not provide specific guidance or outlook figures for future periods in the report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-007334), on September 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.